Terminated PHASE1 INTERVENTIONAL 3-arm NCT02246556

Dichoptic Virtual Reality Therapy for Amblyopia in Adults

Sponsor: University of California, San Francisco

Conditions Amblyopia Anisometropia Strabismus

Interventions Dichoptic therapy Dioptic (non-dichoptic) therapy Patching therapy

Updated 6 times since 2017 Last updated: May 1, 2017 Started: Oct 31, 2014 Primary completion: Apr 30, 2016 Completion: Apr 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Recruitment inadequate and investigators leaving the study institution for new positions.

Other terminated trials from University of California, San Francisco

See all terminations from University of California, San Francisco

Other Amblyopia trials with similar outcome

Browse all Amblyopia trials

This PHASE1 trial investigates Amblyopia and Anisometropia and is currently terminated or withdrawn. University of California, San Francisco leads this study, which shows 6 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1
Jun 2017 — Jun 2018 [monthly]

Terminated PHASE1

Status: Recruiting → Terminated

▶ Show 1 earlier version

Jan 2017 — Jun 2017 [monthly]

Recruiting PHASE1

First recorded

Oct 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of California, San Francisco

Data source: University of California, San Francisco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Francisco, United States